Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Long-Term Investments (2019 - 2023)

Strata Critical Medical (SRTA) has disclosed Long-Term Investments for 5 consecutive years, with $390000.0 as the latest value for Q3 2023.

  • Quarterly Long-Term Investments changed 0.0% to $390000.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $390000.0 through Sep 2023, changed 0.0% year-over-year, with the annual reading at $390000.0 for FY2022, N/A changed from the prior year.
  • Long-Term Investments for Q3 2023 was $390000.0 at Strata Critical Medical, roughly flat from $390000.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $277.2 million in Q2 2020, with the low at $200000.0 in Q3 2020.
  • Average Long-Term Investments over 5 years is $97.8 million, with a median of $390000.0 recorded in 2022.
  • The sharpest move saw Long-Term Investments plummeted 99.93% in 2021, then skyrocketed 95.0% in 2022.
  • Over 5 years, Long-Term Investments stood at $276.3 million in 2019, then increased by 0.25% to $276.9 million in 2020, then plummeted by 99.93% to $200000.0 in 2021, then surged by 95.0% to $390000.0 in 2022, then changed by 0.0% to $390000.0 in 2023.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $390000.0, $390000.0, and $390000.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.